-
A286695-5mgapplication:AZ3451 has been used as a protease-activated receptor 2 (PAR-2) antagonist to study the involvement of PAR-2 receptors in factor X activated (FXa)-induced upregulation of the cell adhesion molecules.
-
A288491-100mgPotent TNKS1/2 inhibitor.
-
A288491-10mgPotent TNKS1/2 inhibitor.
-
A288491-25mgPotent TNKS1/2 inhibitor.
-
A288491-50mgPotent TNKS1/2 inhibitor.
-
A288491-5mgPotent TNKS1/2 inhibitor.
-
A129605-100mgNovel, potent, pan-Raf inhibitor for BRAF, BRAFV600E and c-Raf.
-
A129605-10mgNovel, potent, pan-Raf inhibitor for BRAF, BRAFV600E and c-Raf.
-
A129605-1mgNovel, potent, pan-Raf inhibitor for BRAF, BRAFV600E and c-Raf.
-
A129605-25mgNovel, potent, pan-Raf inhibitor for BRAF, BRAFV600E and c-Raf.
-
A129605-50mgNovel, potent, pan-Raf inhibitor for BRAF, BRAFV600E and c-Raf.
-
A129605-5mgNovel, potent, pan-Raf inhibitor for BRAF, BRAFV600E and c-Raf.